![Konstantin Bloch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Konstantin Bloch
Corporate Officer/Principal at Felsenstein Medical Research Center
Konstantin Bloch active positions
Companies | Position | Start | End |
---|---|---|---|
Felsenstein Medical Research Center | Corporate Officer/Principal | - | - |
Career history of Konstantin Bloch
Former positions of Konstantin Bloch
Companies | Position | Start | End |
---|---|---|---|
Tel-Aviv University
![]() Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Corporate Officer/Principal | - | - |
Beta-O2 Technologies Ltd.
![]() Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Founder | 2003-12-31 | - |
Training of Konstantin Bloch
Kharkiv National University | Undergraduate Degree |
Russian Academy of Sciences | Doctorate Degree |
Statistics
International
Israel | 4 |
Ukraine | 2 |
Russia | 2 |
Operational
Corporate Officer/Principal | 2 |
Founder | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Beta-O2 Technologies Ltd.
![]() Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel. | Health Technology |
Felsenstein Medical Research Center |
- Stock Market
- Insiders
- Konstantin Bloch
- Experience